A major news story from Sanofi this month is that "The European Medicines Agency has approved Dupixent (dupilumab) to treat ...

PARIS, Oct 16 (Reuters) - French unions have called on workers at Sanofi (SASY.PA), opens new tab to strike from Thursday to protest a planned sale of the pharmaceutical group's consumer health ...

PARIS, Oct 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U ...

Bonne nouvelle pour le quartier d'affaires. A l'été 2027, au moins 2.700 des 3.700 salariés du site de Gentilly devraient ...

PARIS (Agefi-Dow Jones)--Le laboratoire pharmaceutique Sanofi a annoncé jeudi que le Comité des médicaments à usage humain ...

Today, Formation Bio, together with OpenAI and Sanofi, introduced Muse, an advanced AI-powered tool developed to accelerate and improve drug development by optimizing patient recruitment for clinical ...

(AOF) - Amundi Amundi a annoncé l'acquisition d'aixigo, société technologique ayant développé une offre de services modulaire pour les ...

PARIS (Reuters) -Sanofi on Sunday reached an agreement on terms to sell a controlling stake in its consumer health unit Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R), French ...

The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.35 per share.

Sanofi a installé à Paris un « accélérateur digital » afin d'intégrer l’intelligence artificielle aux logiciels de recherche.

Paris: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic ...